Community/Retail

A natural aging supplement enhances muscle strength and reduces biological age, promoting healthier aging.

A new multicomponent vaccine, mRNA-1083, shows promise in enhancing immune responses against influenza and COVID-19, addressing vaccine hesitancy effectively.

Maternal cardiometabolic issues during pregnancy significantly elevate children's blood pressure, highlighting the need for preventive health measures.

Pharmacists are positioned to significantly impact weight management by offering accessible expertise in medication, lifestyle guidance, and long-term support for healthier choices.

During a panel discussion, 3 experts highlighted ways health care professionals and researchers can help provide patient-centered care.

Emma Murter, PharmD, MPH, and Madison N. Irwin, PharmD, BCPS, discuss the potential role of low-dose naltrexone in managing chronic pain in palliative care, highlighting its anti-inflammatory properties, limited adverse effects, and current evidence gaps—particularly in comparison to traditional opioids and adjuvant analgesics.

While vaccine research and approvals continue to break new ground, use and faith in them are faltering.

PharmStart empowers pharmacy technicians to pursue their education with tuition-free prerequisites, addressing barriers to entering pharmacy school.

The study found that only 38% of nations have risk-based pneumococcal vaccine policies.

New research reveals a promising strategy to slow type 1 diabetes progression by targeting inflammation with an existing psoriasis drug.

The new at-home test aims to increase comfort and screening timeliness through a more accessible method.

The most substantial reduction was achieved 2 to 3 years after vaccination with a sustained protective effect lasting up to 8 years.

A recent study highlights the promising immune response and safety of the Arexvy vaccine in lung transplant recipients, crucial for preventing RSV infections.

These findings demonstrate an association that is independent of the disease’s genetic predisposition.

Plozasiran shows promise in reducing cholesterol and triglyceride levels in patients with mixed hyperlipidemia and other harmful conditions, addressing significant cardiovascular risks.

Student pharmacists can work toward a better future for patients, themselves, and the profession.

The fixed-dose combination yielded a 49% greater reduction in low density lipoprotein cholesterol (LDL-C) compared with placebo.

New research reveals that B vitamins and choline may slow glaucoma progression, offering hope for innovative treatments beyond traditional methods.

The Ensuring Community Access to Pharmacist Services (ECAPS) Act would enhance Medicare coverage for pharmacist services and ensure seniors can access essential care in underserved areas.

These results build off prior studies which demonstrated effectiveness of Bergen 4-day treatment (B4DT) in patients with panic disorders.

Dracey Poore explores the future of biosimilars, emphasizing the need for increased adoption.

Specialty pharmacy experts discuss how emotional support, addressing patient loneliness, and peer-to-patient programs can significantly improve medication adherence and patient care.

Adherence to GLP-1 receptor agonists showed a 59% drop in inpatient hospital costs.

The 12.5-mg dose tablet enhances hypertension treatment options and reduces adverse effects for patients.

UPMC enhances care for patients with heart failure through integrated pharmacy and cardiology team collaboration.

AI transforms pharmacy practice by streamlining workflows and enhancing patient care, while pharmacists adapt to new roles and challenges in health care.

The time frame concept is an underappreciated through line in most planning efforts.

Experts emphasized the importance of addressing regulatory and payer-side challenges to fully leverage AI's potential in pharmacy settings.